Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Canine Distemper Virus Fusion Glycoprotein F0 (F), N-His-SUMO

Cat. No.VG2C55

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Canine Distemper Virus Fusion Glycoprotein F0 (F), N-His-SUMO is a recombinant protein expressed from E.coli. Its predicted molecular weight is 67.5 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 67.5 kDa
Physical State Lyophilized
Formulation Tris/PBS-based buffer, 5%-50% glycerol

Target Information

The Canine distemper virus fusion glycoprotein F0 (F) is a critical envelope glycoprotein that mediates viral entry into host cells by promoting membrane fusion. It is synthesized as a precursor and cleaved into F1 and F2 subunits, which are essential for viral infectivity. In veterinary medicine, the F protein is a major target for neutralizing antibodies and is crucial for vaccine development. Recombinant F protein has been shown to induce protective immunity in animal models, making it a promising candidate for subunit vaccines against canine distemper.

Protein Canine Distemper Virus Fusion Glycoprotein F0 (F)
Protein Synonym F; Fusion glycoprotein F0 [Cleaved into: Fusion glycoprotein F2; Fusion glycoprotein F1]
Gene ID 1489793
UniProt ID P12569

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket